2008 Annual Meeting | Ethical Controversies in Neurologic Practice

Date Tuesday 04/15/08

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Michael A. Williams, MD, FAAN

Topic(s) Practice Management

Learning Objectives Participants should be able to describe the principles for moral analysis and justification for decisions to accept or refuse parental requests for either therapeutic or nontherapeutic interventions; recognize the boundaries of enhancement and therapy and develop an ethical framework for responding to requests from patients; and understand both the moral and prudential arguments for abandoning the dead donor rule for donating vital organs and the physiologic, legal, and ethical frameworks that support the dead donor rule.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
02:15 PM - 02:20 PM		Introduction Michael A. Williams, MD, FAAN
02:20 PM - 03:05 PM		Cognitive Stimulants and Ethical Principles to Guide Their Use William P. Cheshire, Jr., MD, FAAN
03:05 PM - 03:50 PM		The Limits of Therapeutic and Nontherapeutic Interventions for Children with Neurologic Impairment Lainie Ross, MD, PhD
03:50 PM - 04:00 PM		Questions and Answers
04:00 PM - 04:15 PM		Break
04:15 PM - 05:00 PM		Why Neurologists Should Call for Abandonment of the Dead Donor Rule Thomas I. Cochrane, MD, MBA
05:00 PM - 05:45 PM		It's More Than Pedantic: Why the Dead Donor Rule Matters Michael A. Williams, MD, FAAN
05:45 PM - 06:00 PM		Questions and Answers

Faculty Disclosures
Michael A. Williams, MD, FAAN	Dr. Williams has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for the Hydrocephalus Association, a not-for-profit patient advocacay organization. The institution of Dr. Williams has received research support from NASA. The institution of Dr. Williams has received research support from Translational Research Insitute for Space Health (TRISH). The institution of Dr. Williams has received research support from NINDS.
William P. Cheshire, Jr., MD, FAAN	Dr. Cheshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for oxford university press. Dr. Cheshire has a non-compensated relationship as a Associate Editor with Clinical Autonomic Research that is relevant to AAN interests or activities.
Thomas I. Cochrane, MD, MBA	Dr. Cochrane has received personal compensation for serving as an employee of Biogen, Inc. Dr. Cochrane has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alliance Family of Companies. Dr. Cochrane has received stock or an ownership interest from Biogen.
Lainie Ross, MD, PhD	No disclosure on file

��ɫ��

��ɫ��